These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26452037)

  • 1. Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice.
    Wu B; Wei Y; Wang Y; Su T; Zhou L; Liu Y; He R
    Oncotarget; 2015 Oct; 6(33):34128-42. PubMed ID: 26452037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
    Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
    Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
    Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB
    Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.
    Wei Y; Han C; Wang Y; Wu B; Su T; Liu Y; He R
    Aging Cell; 2015 Oct; 14(5):754-63. PubMed ID: 26095350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide.
    Gardner LE; White JD; Eimerbrink MJ; Boehm GW; Chumley MJ
    Neuroscience; 2016 Sep; 331():72-7. PubMed ID: 27320209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic D-ribose and D-mannose overload induce depressive/anxiety-like behavior and spatial memory impairment in mice.
    Xu K; Wang M; Zhou W; Pu J; Wang H; Xie P
    Transl Psychiatry; 2021 Feb; 11(1):90. PubMed ID: 33531473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and methanol toxicity (part 1): chronic methanol feeding led to memory impairments and tau hyperphosphorylation in mice.
    Yang M; Lu J; Miao J; Rizak J; Yang J; Zhai R; Zhou J; Qu J; Wang J; Yang S; Ma Y; Hu X; He R
    J Alzheimers Dis; 2014; 41(4):1117-29. PubMed ID: 24787915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram Ameliorates Tau Hyperphosphorylation and Spatial Memory Deficits Induced by Protein Kinase A Activation in Sprague Dawley Rats.
    Ren QG; Wang YJ; Gong WG; Xu L; Zhang ZJ
    J Alzheimers Dis; 2015; 47(1):61-71. PubMed ID: 26402755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin.
    Lu F; Li X; Suo AQ; Zhang JW
    Chin Med J (Engl); 2010 Jul; 123(14):1864-70. PubMed ID: 20819569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.
    Li L; Zhang ZF; Holscher C; Gao C; Jiang YH; Liu YZ
    Eur J Pharmacol; 2012 Jan; 674(2-3):280-6. PubMed ID: 22115895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.